Utah Medical Products, Inc. (NASDAQ:UTMD) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 107,000 shares, a growth of 33.4% from the May 30th total of 80,200 shares. Based on an average trading volume of 21,500 shares, the short-interest ratio is presently 5.0 days. Currently, 3.1% of the company’s shares are short sold.
Separately, BidaskClub lowered Utah Medical Products from a “hold” rating to a “sell” rating in a research report on Monday, July 8th.
A number of hedge funds and other institutional investors have recently modified their holdings of UTMD. Rice Hall James & Associates LLC raised its position in Utah Medical Products by 90.8% during the 1st quarter. Rice Hall James & Associates LLC now owns 44,989 shares of the medical instruments supplier’s stock valued at $3,970,000 after purchasing an additional 21,407 shares in the last quarter. FMR LLC increased its holdings in shares of Utah Medical Products by 2.4% in the 1st quarter. FMR LLC now owns 488,255 shares of the medical instruments supplier’s stock valued at $43,089,000 after acquiring an additional 11,248 shares during the period. BlackRock Inc. increased its holdings in shares of Utah Medical Products by 4.9% in the 4th quarter. BlackRock Inc. now owns 189,228 shares of the medical instruments supplier’s stock valued at $15,721,000 after acquiring an additional 8,765 shares during the period. Ranger Investment Management L.P. increased its holdings in shares of Utah Medical Products by 12.4% in the 4th quarter. Ranger Investment Management L.P. now owns 49,816 shares of the medical instruments supplier’s stock valued at $4,139,000 after acquiring an additional 5,512 shares during the period. Finally, Affinity Investment Advisors LLC purchased a new position in shares of Utah Medical Products in the 1st quarter valued at $362,000. 73.63% of the stock is owned by institutional investors and hedge funds.
Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Thursday, April 25th. The medical instruments supplier reported $0.84 earnings per share for the quarter. The business had revenue of $10.73 million during the quarter. Utah Medical Products had a return on equity of 16.47% and a net margin of 42.07%.
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 3rd. Shareholders of record on Friday, June 14th were given a dividend of $0.275 per share. This represents a $1.10 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date was Thursday, June 13th.
Utah Medical Products Company Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.
Further Reading: How does the Beige Book influence monetary policy?
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.